title: [Kidney retransplantation: prognostic factors in a series of 84 cases].
abstract: Results are presented of a series of 84 patients receiving renal retransplants over the last 12 years. One year survival rate of patients and transplants was 87.6% and 79.1% respectively, compared with 92.5% and 81.2% for the 783 first grafts performed during the same period. Positive prognostic features were the absence of sensitization, survival of the first transplant for more than 6 months, and the inclusion of cyclosporin in the immunodepressive treatment.
authors.affiliation: Chaire et Service d'Urologie, Hôpital Clinico y Provincial de Barcelone, Espagne.
authors.forename: R
authors.initials: R
authors.lastname: Gutierrez
authors.forename: J A
authors.initials: JA
authors.lastname: Romero
authors.forename: J M
authors.initials: JM
authors.lastname: Ricart
authors.forename: M
authors.initials: M
authors.lastname: Barranco
authors.forename: P
authors.initials: P
authors.lastname: Oppenheimer
authors.forename: R
authors.initials: R
authors.lastname: Alvarez
authors.forename: R
authors.initials: R
authors.lastname: Talbot
authors.forename: P
authors.initials: P
authors.lastname: Carretero
mesh_terms: D000206:Actuarial Analysis; D000293:Adolescent; D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D002648:Child; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006084:Graft Rejection; D006801:Humans; D016030:Kidney Transplantation / Q000401:mortality*; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D011379:Prognosis; D012086:Reoperation
chemical_list: D000961:Antilymphocyte Serum; D016572:Cyclosporine; D001379:Azathioprine; D011241:Prednisone
vernacular_title: La retransplantation rénale (RT): facteurs pronostiques dans une série de 84 cas.